Search results
Results from the WOW.Com Content Network
Cognitive disengagement syndrome ( CDS) is an attention syndrome characterised by prominent dreaminess, mental fogginess, hypoactivity, sluggishness, slow reaction time, staring frequently, inconsistent alertness, and a slow working speed. To scientists in the field, it has reached the threshold of evidence and recognition as a distinct syndrome.
Adult Attention Deficit Hyperactivity Disorder is the persistence of attention deficit hyperactivity disorder (ADHD) into adulthood. It is a neurodevelopmental disorder, meaning impairing symptoms must have been present in childhood, except for when ADHD occurs after traumatic brain injury. [1] [2] [3] Specifically, multiple symptoms must be ...
Attention deficit hyperactivity disorder predominantly inattentive ( ADHD-PI or ADHD-I ), [3] is one of the three presentations of attention deficit hyperactivity disorder (ADHD). [4] In 1987–1994, there were no subtypes or presentations and thus it was not distinguished from hyperactive ADHD in the Diagnostic and Statistical Manual (DSM-III-R). In DSM-5, subtypes were discarded and ...
The terminology used to describe the symptoms of attention deficit hyperactivity disorder, or ADHD, has gone through many changes over history, including "minimal brain damage", "minimal brain dysfunction", "learning/behavioral disabilities" and "hyperactivity".
ADHD is estimated to affect about 6 to 7 percent of people aged 18 and under when diagnosed via the DSM-IV criteria. [3] When diagnosed via the ICD-10 criteria, hyperkinetic disorder (the ICD-10 term for severe ADHD) gives rates between 1 and 2 percent in this age group. [4] [5]
Attention deficit hyperactivity disorder controversies. Despite their safety and effectiveness in treating ADHD symptoms, [1] the use of methylphenidate and other stimulant medications is frequently a topic of public controversy. Despite the scientifically well-established nature of attention deficit hyperactivity disorder (ADHD), its diagnosis ...
Additionally, ICD-9-CM codes updated since the release of DSM-IV were incorporated. [4] Both the DSM-IV and DSM-IV-TR encompass a total of 297 mental disorders.
Atomoxetine. Atomoxetine, sold under the brand name Strattera, is a selective norepinephrine reuptake inhibitor medication used to treat attention deficit hyperactivity disorder (ADHD) [12] and, to a lesser extent, cognitive disengagement syndrome. [13] [14] [15] It may be used alone or along with psychostimulants.